{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:36:55Z","timestamp":1780115815130,"version":"3.54.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:00:00Z","timestamp":1696204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:00:00Z","timestamp":1696204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200225"],"award-info":[{"award-number":["82200225"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Castleman\u2019s disease (CD) is a rare disease that has clinical and pathological similarities to lymphoma and is characterized by a high frequency of associated immunological dysfunction. ImmunoglobulinG4-related disease (IgG4-RD) is a collection of systemic disorders that affect numerous organs and are also referred to as IgG4-associated sclerosing diseases. CD and IgG4-RD are difficult to separate because they may manifest similar commin clinical features.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>This case describes a 53-year-old female who, during routine medical check-up, exhibited a progressive increase in serum globulin levels and a simultaneous worsening of anemia symptoms, raising concern for a clonal plasma cell disease such as myeloma. However, bone marrow punctures did not reveal any abnormal plasma cells. Also, serum and urine immunofixation electrophoresis demonstrated no abnormal monoclonal protein bands. In addition, several laboratory findings excluded chronic liver disease, chronic infections caused by bacteria or viruses. Later, we found elevated serum IgG4 levels (10,700\u00a0mg\/L), and identified multiple enlarged lymph nodes throughout the patient\u2019s body. Axillary lymph node aspiration revealed no abnormal lymphocytes, ruling out the possibility of lymphoma. Pathological morphology of the axillary lymph revealed a large number of plasma cells in the lymphatic follicles. In addition, there was a reduction in lymphatic follicle size and apoptosis of the germinal centres. Immunohistochemistry revealed IgG4+\/IgG\u2009+\u2009in &gt;\u200940% of cells, and more than 100 IgG4\u2009+\u2009cells per high powered field (HPF) of specimen. As of now, finding strongly suggested IgG4-RD. This patient was treated with glucocorticoids and various immunosuppressive drugs, such as prednisone, cyclosporine, methotrexate, cyclophosphamide, mycophenolate mofetil, azathioprine and hydroxychloroquine. Unfortunately, the patient did not recover. Ultimately, idiopathic multicentric Castleman disease (iMCD) was diagnosed in relation to the patient\u2019s clinical presentation and laboratory tests, and after combination chemotherapy (VCD: Bortezomib, Cyclophosphamide and Dexamethasone), durable remission was achieved without serious adverse effects. During the follow-up period of one year and ten months, the patient remained stable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The diagnosis of Castleman must be distinguished from other disorders such as IgG4-RD, malignant lymphoma, reactive hyperplasia of various lymph nodes (mostly caused by viral infections), plasmacytoma, advanced HIV and rheumatic diseases. Besides observing systemic symptoms, laboratory tests such as immunoglobulin levels, complement levels, interleukin levels, and C-reactive protein levels should also be performed in order to determine a diagnosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-023-03335-7","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T15:01:33Z","timestamp":1696258893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Idiopathic multicentric castleman\u2019s disease mimicking immunoglobulin G4-related disease responding well to Bortezomib: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Qian","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhitao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,2]]},"reference":[{"issue":"3","key":"3335_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/00000658-195803000-00018","volume":"147","author":"K Inada","year":"1958","unstructured":"Inada K, Hamazaki M. Localized mediastinal lymph-node hyperplasia resembling thymoma; a case report. Ann Surg. 1958;147(3):409\u201313.","journal-title":"Ann Surg"},{"issue":"3","key":"3335_CR2","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#","volume":"29","author":"AR Keller","year":"1972","unstructured":"Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29(3):670\u201383.","journal-title":"Cancer"},{"issue":"1","key":"3335_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41572-021-00317-7","volume":"7","author":"A Carbone","year":"2021","unstructured":"Carbone A, Borok M, Damania B, Gloghini A, Polizzotto MN, Jayanthan RK, et al. Castleman disease. Nat Rev Dis Primers. 2021;7(1):84.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"3335_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.7326\/0003-4819-128-8-199804150-00010","volume":"128","author":"J Herrada","year":"1998","unstructured":"Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med. 1998;128(8):657\u201362.","journal-title":"Ann Intern Med"},{"issue":"9","key":"3335_CR5","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1200\/JCO.1985.3.9.1202","volume":"3","author":"G Frizzera","year":"1985","unstructured":"Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphologic features of Castleman\u2019s disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol. 1985;3(9):1202\u201316.","journal-title":"J Clin Oncol"},{"issue":"19","key":"3335_CR6","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1182\/blood-2013-12-545087","volume":"123","author":"DC Fajgenbaum","year":"2014","unstructured":"Fajgenbaum DC, van Rhee F, Nabel CS. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood. 2014;123(19):2924\u201333.","journal-title":"Blood"},{"issue":"4","key":"3335_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1177\/107327481402100403","volume":"21","author":"JD Soumerai","year":"2014","unstructured":"Soumerai JD, Sohani AR, Abramson JS. Diagnosis and management of Castleman disease. Cancer Control. 2014;21(4):266\u201378.","journal-title":"Cancer Control"},{"issue":"12","key":"3335_CR8","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","volume":"129","author":"DC Fajgenbaum","year":"2017","unstructured":"Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease. Blood. 2017;129(12):1646\u201357.","journal-title":"Blood"},{"issue":"10","key":"3335_CR9","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1002\/art.34593","volume":"64","author":"JH Stone","year":"2012","unstructured":"Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64(10):3061\u20137.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3335_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181\u201392.","journal-title":"Mod Pathol"},{"issue":"2","key":"3335_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/bjh.15019","volume":"180","author":"E Oksenhendler","year":"2018","unstructured":"Oksenhendler E, Boutboul D, Fajgenbaum D, Mirouse A, Fieschi C, Malphettes M, et al. The full spectrum of Castleman disease: 273 patients studied over 20 years. Br J Haematol. 2018;180(2):206\u201316.","journal-title":"Br J Haematol"},{"key":"3335_CR12","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.3389\/fimmu.2019.01489","volume":"10","author":"A Leurs","year":"2019","unstructured":"Leurs A, Gnemmi V, Lionet A, Renaud L, Gibier JB, Copin MC, et al. Renal pathologic findings in TAFRO syndrome: is there a Continuum between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review. Front Immunol. 2019;10:1489.","journal-title":"Front Immunol"},{"issue":"1","key":"3335_CR13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1186\/s12882-020-02119-7","volume":"21","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Zhang Y, Zhou G, Zhu J. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature. BMC Nephrol. 2020;21(1):499.","journal-title":"BMC Nephrol"},{"issue":"16","key":"3335_CR14","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1182\/blood.2019000931","volume":"135","author":"A Dispenzieri","year":"2020","unstructured":"Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood. 2020;135(16):1353\u201364.","journal-title":"Blood"},{"issue":"1","key":"3335_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/BOR.0b013e3283412f7c","volume":"23","author":"JR Stone","year":"2011","unstructured":"Stone JR. Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23(1):88\u201394.","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"3335_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.neurad.2021.01.006","volume":"48","author":"F Behzadi","year":"2021","unstructured":"Behzadi F, Suh CH, Jo VY, Shanmugam V, Morgan EA, Guenette JP. Imaging of IgG4-Related disease in the Head and Neck: a systematic review, Case Series, and Pathophysiology Update. J Neuroradiol. 2021;48(5):369\u201378.","journal-title":"J Neuroradiol"},{"issue":"5","key":"3335_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/jop.13296","volume":"51","author":"GG Pereira","year":"2022","unstructured":"Pereira GG, Pontes FSC, Soares CD, de Carvalho MGF, da Silva TA, Calderaro DC, et al. Oral and maxillofacial manifestations of IgG4-related disease: a clinicopathological study. J Oral Pathol Med. 2022;51(5):493\u2013500.","journal-title":"J Oral Pathol Med"},{"issue":"6","key":"3335_CR18","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.semarthrit.2020.09.002","volume":"50","author":"H Liu","year":"2020","unstructured":"Liu H, Wallace ZS, Harvey L, Crotty R, Wu CL, Deshpande V, et al. Prostate and pancreas involvement are linked in IgG4-related disease. Semin Arthritis Rheum. 2020;50(6):1245\u201351.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"3335_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/modpathol.2009.17","volume":"22","author":"Y Sato","year":"2009","unstructured":"Sato Y, Kojima M, Takata K, Morito T, Asaoku H, Takeuchi T, et al. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman\u2019s disease. Mod Pathol. 2009;22(4):589\u201399.","journal-title":"Mod Pathol"},{"issue":"20","key":"3335_CR20","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1182\/blood-2018-07-862334","volume":"132","author":"F van Rhee","year":"2018","unstructured":"van Rhee F, Voorhees P, Dispenzieri A, Fossa A, Srkalovic G, Ide M, et al. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018;132(20):2115\u201324.","journal-title":"Blood"},{"issue":"2","key":"3335_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s40262-018-0679-9","volume":"58","author":"CRC Tan","year":"2019","unstructured":"Tan CRC, Abdul-Majeed S, Cael B, Barta SK. Clinical pharmacokinetics and pharmacodynamics of Bortezomib. Clin Pharmacokinet. 2019;58(2):157\u201368.","journal-title":"Clin Pharmacokinet"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03335-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03335-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03335-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T06:05:33Z","timestamp":1700460333000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03335-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,2]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3335"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03335-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,2]]},"assertion":[{"value":"9 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and clinical images were obtained from the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"290"}}